Mechanism-informed neuroprotection in acute ischemic stroke treated with thrombectomy: a systematic review and meta-analysis of randomized controlled trials
Yuchen Wang, Jie Xu, Zhiheng Zhao, Ruizhe Yang, Xin Zhou, Zhang Yang · 2026
Read Mechanism-informed neuroprotection in acute ischemic stroke treated with thrombectomy: a systematic review and meta-analysis of randomized controlled trials by Yuchen Wang, Jie Xu, Zhiheng Zhao, Ruizhe Yang, Xin Zhou, Zhang Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318870.txt.
Description
Yuchen Wang and co-authors present a 2026 systematic review and meta-analysis of neuroprotective drugs added to clot-removal treatment for acute stroke. Thrombectomy reopens big vessels, yet many patients never regain independence. Reperfusion injury at tissue level is a key reason. Searches covered three databases to January 31, 2026.
Nine randomised trials with 4,420 patients were included. Added neuroprotection modestly raised functional independence at 90 days. The odds ratio was 1.13 against control in the pooled result. Most other outcomes showed no clear benefit. Death, symptomatic bleeding, and serious side effects did not differ. Timing and reperfusion context may shape who benefits. The authors call this a weak, mixed signal needing mechanism-guided trials.
Catalog record
| CREATOR | Yuchen Wang, Jie Xu, Zhiheng Zhao, Ruizhe Yang, Xin Zhou, Zhang Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53299 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |